Fielmann AG (ADR)
General ticker "FLMNY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $4.5B (TTM average)
Fielmann AG (ADR) follows the US Stock Market performance with the rate: 29.4%.
Estimated limits based on current volatility of 0.0%: low 11.75$, high 11.75$
Factors to consider:
- Company pays dividends (annually): last record date 2025-07-14, amount 0.27$ (Y2.30%)
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [8.51$, 12.59$]
- 2025-12-31 to 2026-12-31 estimated range: [9.43$, 13.81$]
Financial Metrics affecting the FLMNY estimates:
- Positive: with PPE of 14.0 at the end of fiscal year the price was very low
- Positive: 7.86 < Operating profit margin, % of 15.09
- Negative: Industry operating cash flow per share per price (median), % of 0.78 <= 5.52
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Industry inventory ratio change (median), % of 1.55 > 0.28
- Negative: Investing cash flow per share per price, % of -9.53 <= -4.48
- Positive: 6.82 < Operating cash flow per share per price, % of 11.80
- Positive: 18.93 < Shareholder equity ratio, % of 37.95 <= 41.86
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 6.03
- Negative: 0.79 < Interest expense per share per price, % of 1.20
- Positive: Inventory ratio change, % of 0.03 <= 0.84
Short-term FLMNY quotes
Long-term FLMNY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €1,759.05MM | €1,969.08MM | €2,264.12MM |
| Operating Expenses | €1,523.61MM | €1,682.53MM | €1,922.44MM |
| Operating Income | €235.44MM | €286.55MM | €341.68MM |
| Non-Operating Income | €-75.06MM | €-92.83MM | €-122.83MM |
| Interest Expense | €8.22MM | €23.75MM | €41.87MM |
| Income(Loss) | €160.37MM | €193.72MM | €218.85MM |
| Taxes | €50.64MM | €63.08MM | €64.64MM |
| Profit(Loss)* | €103.66MM | €127.64MM | €152.11MM |
| Stockholders Equity | €804.22MM | €792.02MM | €899.13MM |
| Inventory | €183.25MM | €224.74MM | €259.32MM |
| Assets | €1,766.74MM | €1,986.55MM | €2,368.95MM |
| Operating Cash Flow | €244.97MM | €282.79MM | €410.09MM |
| Capital expenditure | €85.39MM | €86.79MM | €82.69MM |
| Investing Cash Flow | €-159.85MM | €-143.25MM | €-331.17MM |
| Financing Cash Flow | €-209.22MM | €-132.00MM | €-44.27MM |
| Earnings Per Share** | €0.25 | €0.30 | €0.36 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.